IRIS PubliCatt

Mantini, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.141
NA - Nord America 3.046
AS - Asia 931
SA - Sud America 23
AF - Africa 18
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 7.186
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.979
DE - Germania 1.402
SE - Svezia 538
CN - Cina 453
UA - Ucraina 270
IT - Italia 253
SG - Singapore 182
FR - Francia 145
IE - Irlanda 139
IN - India 112
GB - Regno Unito 110
ID - Indonesia 88
RU - Federazione Russa 61
CA - Canada 56
PL - Polonia 56
FI - Finlandia 51
TR - Turchia 48
BE - Belgio 35
CZ - Repubblica Ceca 30
AU - Australia 15
CI - Costa d'Avorio 14
IR - Iran 14
BR - Brasile 11
BZ - Belize 10
JP - Giappone 10
CH - Svizzera 8
EU - Europa 8
NL - Olanda 8
CL - Cile 6
PT - Portogallo 6
AT - Austria 5
ES - Italia 5
KR - Corea 5
NO - Norvegia 5
RO - Romania 4
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BG - Bulgaria 2
DZ - Algeria 2
GR - Grecia 2
HK - Hong Kong 2
HU - Ungheria 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
SA - Arabia Saudita 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
BD - Bangladesh 1
BH - Bahrain 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 7.186
Salva come PNG Salva come JPEG
Città #
Chandler 666
Ashburn 226
Jacksonville 156
Ann Arbor 145
Dublin 138
San Mateo 138
Singapore 124
Nanjing 106
Nürnberg 100
Dearborn 98
Houston 92
Jakarta 88
Woodbridge 83
Wilmington 81
Boston 59
New York 58
Redwood City 57
Marseille 51
Warsaw 48
Bremen 46
Nanchang 46
Cattolica 45
Fairfield 45
Princeton 44
Izmir 43
Moscow 42
Beijing 40
Milan 38
Redmond 38
Lawrence 37
Brussels 34
Los Angeles 33
Munich 31
San Jose 27
Hebei 22
Leawood 22
North York 21
Rome 21
Seattle 21
Toronto 21
Kunming 20
Tianjin 19
Hangzhou 18
Jiaxing 18
Shenyang 17
Mountain View 16
Boardman 15
Abidjan 14
Shanghai 14
Chicago 13
Albuquerque 12
Enterprise 12
San Diego 12
Washington 12
Zhengzhou 12
Andover 11
Changsha 11
Belize City 10
Falls Church 9
Fremont 9
Hefei 9
University Park 9
Cambridge 8
Lancaster 8
Las Vegas 8
Norwalk 8
Pune 8
Castelnuovo 7
Saint Louis 7
Auburn Hills 6
Bologna 6
Brno 6
Changchun 6
Helsinki 6
Jinan 6
Augusta 5
Detroit 5
London 5
Monmouth Junction 5
Ottawa 5
Phoenix 5
San Francisco 5
Atlanta 4
Bari 4
Berlin 4
Bern 4
Fuzhou 4
Kraków 4
Melbourne 4
Philadelphia 4
São Paulo 4
Vienna 4
Xian 4
Ardabil 3
Buffalo 3
Columbus 3
Düsseldorf 3
Edmonton 3
Guangzhou 3
Indiana 3
Totale 3.713
Salva come PNG Salva come JPEG
Nome #
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 236
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 223
Pros-IT CNR: an Italian prostate cancer monitoring project 211
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 207
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 171
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 163
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 160
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 158
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 142
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 139
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 138
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 133
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 133
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 131
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 128
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial 128
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 126
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 118
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 117
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 117
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study 117
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 113
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 112
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 112
Radiotherapy vs Follow up in the treatment of pathological stage Ia and Ib non small cell lung cancer. Early stopped analysis of a randomized controlled study. 108
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 108
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 108
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 101
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 100
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 100
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 99
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 96
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. 96
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 95
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 95
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 93
Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis. 92
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 88
Role of radiotherapy in the treatment of fibrosarcoma of the spermatic cord: a case report and review of the literature 86
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 86
Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome 82
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 80
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 79
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 79
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 78
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 77
Can automation in radiotherapy reduce costs? 73
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 73
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 71
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 68
OncotypeDX (R) predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis-ADAPTED01 67
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 66
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 64
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 64
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 63
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology 61
Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy 59
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 59
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 58
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: Low-dose fractionated radiotherapy with concurrent chemotherapy 58
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 58
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 58
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 56
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 53
Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial 53
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 49
Breakthrough pain management in patients undergoing radiotherapy: A national survey on behalf of the Palliative and Supportive Care Study Group 47
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 47
776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER 47
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 47
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 46
Radiotherapy plus GnRH analogue versus high dose bicalutamide: A case control study 45
BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer 38
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 34
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study 33
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 32
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: An Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study 29
Impact of dose and volume on radiation-induced mucositis 22
Split course concomitant radiochemotherapy followed by brachytherapy boost in the exclusive treatment of the anal canal cancer 16
Preoperative radiotherapy in gastric cancer: CTV definition for conformal therapy according to tumor location 15
Spider: Managing clinical data of cancer patients treated through a multidisciplinary approach by a palm based system 14
Chemoradiation with raltitrexed (TOMUDEX) in preoperative treatment of stage II-III resectable rectal cancer: A phase II study 10
Quality handbook in radiotherapy: personal experience 10
External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study 9
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure 9
Totale 7.340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.112
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020911 0 0 0 64 134 111 124 47 120 57 174 80
2020/2021783 54 72 38 94 148 53 84 27 86 37 81 9
2021/2022849 77 57 16 58 52 45 27 134 34 67 132 150
2022/20231.770 254 250 149 303 102 208 88 126 203 13 47 27
2023/2024724 33 207 20 69 29 95 16 55 11 22 78 89
2024/2025243 49 49 118 27 0 0 0 0 0 0 0 0
Totale 7.340